Skip to content

Back Jupiter Life Line Hospitals IPO Day 2: Issue subscribed 3.30 times; retail portion booked 3.08x

Jupiter Lifeline Hospitals IPO Subscription Status: On day 2, 3.30 times were subscribed to the IPO of Jupiter Lifeline Hospitals. The subscription period for the Jupiter Lifeline Hospital Initial Public Offering (IPO) began on September 6 and ends on September 8.

On day 2, retail investors, non-institutional investors (NIIS), and qualified institutional buyers (QIBs) responded well to the Jupiter Lifeline Hospital IPO.

PROMOTED
Receive a Guaranteed Income with a 110% ROP for up to 30 years.
Sponsored: ICICI Pru Life Savings Plan
Power Gummies with Health & Flavor: A Reliable Option | Sponsored
Do you possess any of the three equities that HDFC Securities advises purchasing for the upcoming two to three quarters?
Mint Live
For a higher quality of life and career, relocate to Canada!
Canada Make Home | Sponsored
A 2:1 bonus share issuance has been announced by Multibagger Stock. Read more here.
Skilled Professionals are required by Live Mint Canada!
Toronto Immigration | Sponsored
You and other qualified professionals are wanted in Canada!
Immigration Canada | Sponsored
Obtain Better Results with Data Query Workflow Studio 3T | Sponsored

Retail investors' shares in the Jupiter Lifeline Hospital IPO were subscribed 3.08 times, NII shares were subscribed 6.63 times, and QIB shares were subscribed 1.12 times.

Subscription status for the IPO of Jupiter Lifeline Hospitals
According to BSE data, bids for 2,80,59,600 shares of the Jupiter Lifeline Hospital IPO have been received compared to the 84,97,169 shares that are being offered.

The retail investors' component of the Jupiter Lifeline Hospital IPO got bids for 1,32,13,560 shares compared to the 42,87,002 shares that were on sale for this segment.

Author

Daniel Jack

For Daniel, journalism is a way of life. He lives and breathes art and anything even remotely related to it. Politics, Cinema, books, music, fashion are a part of his lifestyle.

Comments

Latest